Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature Verena BergkWalter E. HaefeliMeret Martin-Facklam Special Article 28 June 2005 Pages: 327 - 335
Effects of orange juice on the pharmacokinetics of atenolol J. J. LiljaK. RaaskaP. J. Neuvonen Special Article 28 June 2005 Pages: 337 - 340
Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin M. DepréA. Van HeckenJ. N. de Hoon Clinical Trials 28 June 2005 Pages: 341 - 346
Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study I. MahéJ. F. BergmannC. Caulin Clinical Trials 25 June 2005 Pages: 347 - 351
Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension Futoshi AnanNaohiko TakahashiHironobu Yoshimatsu Clinical Trials 26 May 2005 Pages: 353 - 359
A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer’s disease Roberto RaschettiMarina MagginiNicola Vanacore Clinical Trials 24 May 2005 Pages: 361 - 368
Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients Tuomo NieminenHannu UusitaloMika Kähönen Pharmacodynamics 24 May 2005 Pages: 369 - 374
Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection Barbara Gawrońska-SzklarzJoanna WrześniewskaMarek Droździk Pharmacogenetics 23 June 2005 Pages: 375 - 379
Warfarin dose related to apolipoprotein E (APOE) genotype Hugo KohnkeKristina SörlinMia Wadelius Pharmacogenetics 11 June 2005 Pages: 381 - 388
Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients Mateusz KurzawskiMarek DroździkJan Lubiński Pharmacogenetics 24 May 2005 Pages: 389 - 394
Thiopurine S-methyltransferase as a target for drug interactions Hua-Wen XinChristine FischerUlrich Klotz Pharmacokinetics and Disposition 11 June 2005 Pages: 395 - 398
Dermal absorption of permethrin following topical administration D. Tomalik-ScharteA. LazarU. Fuhr Pharmacokinetics and Disposition 10 June 2005 Pages: 399 - 404
Transfer of rofecoxib into human milk Sharon J. GardinerEvan J. BeggRuth C. E. Hughes Pharmacokinetics and Disposition 10 June 2005 Pages: 405 - 408
Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance Marie AntignacJean Sebastien HulotSaïk Urien Pharmacokinetics and Disposition 01 July 2005 Pages: 409 - 416
Cardiovascular drug utilisation and socio-economic inequalities in 20 districts of the Czech Republic Kvetoslava GoreckaAlena LinhartovaIvan Tilser Pharmacoepidemiology and Prescription 28 June 2005 Pages: 417 - 423
Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal anti-inflammatory drugs Arja Helin-SalmivaaraRisto HuupponenTimo Klaukka Pharmacoepidemiology and Prescription 11 June 2005 Pages: 425 - 431
Continuity of long-term medication use after surgical hospital stay I. HachU. MaywaldW. Kirch Pharmacoepidemiology and Prescription 10 June 2005 Pages: 433 - 438
Main comedications associated with major bleeding during anticoagulant therapy with coumarins Fernie Penning-van BeestJoëlle ErkensRon Herings Pharmacoepidemiology and Prescription 10 June 2005 Pages: 439 - 444
Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological study Patrick MaisonPatrick CuninIsabelle Macquin-Mavier Pharmacoepidemiology and Prescription 07 June 2005 Pages: 445 - 451
Impact of inappropriate drug use among hospitalized older adults Graziano OnderFrancesco LandiRoberto Bernabei Pharmacoepidemiology and Prescription 24 May 2005 Pages: 453 - 459
Uptake of angiotensin II receptor blockers in the treatment of hypertension Jacoba P. GrevingPetra DenigFlora M. Haaijer-Ruskamp Pharmacoepidemiology and Prescription 24 May 2005 Pages: 461 - 466
Cyanamide-induced aplastic anemia Elena BallarínLuisa IbáñezJoan-Ramon Laporte Short Communication 01 July 2005 Pages: 467 - 469
Adverse drug reactions related to drugs used in orthostatic hypotension: a prospective and systematic pharmacovigilance study in France Atul PathakValérie RaoulJean-Michel Senard Short Communication 01 July 2005 Pages: 471 - 474
Scientific drug information in newspapers: sensationalism and low quality. The example of therapeutic use of cannabinoids Eva MontanéMarta DuranAlbert Figueras Short Communication 28 June 2005 Pages: 475 - 477
Communication of findings in pharmacovigilance: use of the term “signal” and the need for precision in its use Manfred HaubenLester Reich Letter to the Editors 01 July 2005 Pages: 479 - 480